nodes	percent_of_prediction	percent_of_DWPC	metapath
Aluminum hydroxide—Haemolysis—Cisplatin—peripheral nervous system neoplasm	0.0558	0.0558	CcSEcCtD
Aluminum hydroxide—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.0442	0.0442	CcSEcCtD
Aluminum hydroxide—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.0442	0.0442	CcSEcCtD
Aluminum hydroxide—Lung disorder—Topotecan—peripheral nervous system neoplasm	0.0392	0.0392	CcSEcCtD
Aluminum hydroxide—Lung disorder—Tretinoin—peripheral nervous system neoplasm	0.0388	0.0388	CcSEcCtD
Aluminum hydroxide—Lung disorder—Isotretinoin—peripheral nervous system neoplasm	0.0388	0.0388	CcSEcCtD
Aluminum hydroxide—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.0335	0.0335	CcSEcCtD
Aluminum hydroxide—Venous thrombosis—Cisplatin—peripheral nervous system neoplasm	0.0329	0.0329	CcSEcCtD
Aluminum hydroxide—Extravasation—Topotecan—peripheral nervous system neoplasm	0.0318	0.0318	CcSEcCtD
Aluminum hydroxide—Extravasation—Melphalan—peripheral nervous system neoplasm	0.0311	0.0311	CcSEcCtD
Aluminum hydroxide—Lung disorder—Alitretinoin—peripheral nervous system neoplasm	0.0294	0.0294	CcSEcCtD
Aluminum hydroxide—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.0286	0.0286	CcSEcCtD
Aluminum hydroxide—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.0258	0.0258	CcSEcCtD
Aluminum hydroxide—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.0232	0.0232	CcSEcCtD
Aluminum hydroxide—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.0232	0.0232	CcSEcCtD
Aluminum hydroxide—Extravasation—Vincristine—peripheral nervous system neoplasm	0.023	0.023	CcSEcCtD
Aluminum hydroxide—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.0203	0.0203	CcSEcCtD
Aluminum hydroxide—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.0198	0.0198	CcSEcCtD
Aluminum hydroxide—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.0189	0.0189	CcSEcCtD
Aluminum hydroxide—Extravasation—Etoposide—peripheral nervous system neoplasm	0.0186	0.0186	CcSEcCtD
Aluminum hydroxide—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.0176	0.0176	CcSEcCtD
Aluminum hydroxide—Venous thrombosis—Epirubicin—peripheral nervous system neoplasm	0.0169	0.0169	CcSEcCtD
Aluminum hydroxide—Venous thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Aluminum hydroxide—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.015	0.015	CcSEcCtD
Aluminum hydroxide—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Aluminum hydroxide—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.0137	0.0137	CcSEcCtD
Aluminum hydroxide—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Aluminum hydroxide—Lung disorder—Epirubicin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Aluminum hydroxide—Lung disorder—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Aluminum hydroxide—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.0105	0.0105	CcSEcCtD
Aluminum hydroxide—Infection—Topotecan—peripheral nervous system neoplasm	0.00982	0.00982	CcSEcCtD
Aluminum hydroxide—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00981	0.00981	CcSEcCtD
Aluminum hydroxide—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00981	0.00981	CcSEcCtD
Aluminum hydroxide—Infection—Tretinoin—peripheral nervous system neoplasm	0.00975	0.00975	CcSEcCtD
Aluminum hydroxide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00975	0.00975	CcSEcCtD
Aluminum hydroxide—Oedema—Melphalan—peripheral nervous system neoplasm	0.00968	0.00968	CcSEcCtD
Aluminum hydroxide—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00967	0.00967	CcSEcCtD
Aluminum hydroxide—Infection—Melphalan—peripheral nervous system neoplasm	0.00962	0.00962	CcSEcCtD
Aluminum hydroxide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00802	0.00802	CcSEcCtD
Aluminum hydroxide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00797	0.00797	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00782	0.00782	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00775	0.00775	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00775	0.00775	CcSEcCtD
Aluminum hydroxide—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00768	0.00768	CcSEcCtD
Aluminum hydroxide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00743	0.00743	CcSEcCtD
Aluminum hydroxide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00739	0.00739	CcSEcCtD
Aluminum hydroxide—Oedema—Vincristine—peripheral nervous system neoplasm	0.00716	0.00716	CcSEcCtD
Aluminum hydroxide—Infection—Vincristine—peripheral nervous system neoplasm	0.00712	0.00712	CcSEcCtD
Aluminum hydroxide—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00711	0.00711	CcSEcCtD
Aluminum hydroxide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00665	0.00665	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00634	0.00634	CcSEcCtD
Aluminum hydroxide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00633	0.00633	CcSEcCtD
Aluminum hydroxide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00629	0.00629	CcSEcCtD
Aluminum hydroxide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00615	0.00615	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Aluminum hydroxide—Infection—Etoposide—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Aluminum hydroxide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Aluminum hydroxide—Infection—Epirubicin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Aluminum hydroxide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Aluminum hydroxide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Aluminum hydroxide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
